Rinath M. Jeselsohn, MD, on breast cancer treatment | Dana-Farber Cancer Institute

Rinath M. Jeselsohn, MD, on breast cancer treatment | Dana-Farber Cancer Institute

Treatment for Early Stage HER2+ Breast Cancer | Dana-Farber Cancer InstituteПодробнее

Treatment for Early Stage HER2+ Breast Cancer | Dana-Farber Cancer Institute

Antonio Giordano, MD, PhD, Breast Cancer Physician | Dana-Farber Cancer InstituteПодробнее

Antonio Giordano, MD, PhD, Breast Cancer Physician | Dana-Farber Cancer Institute

Spotlight Session: "Transcriptional reprogramming, ESR1 mutations, and novel targets and treatment"Подробнее

Spotlight Session: 'Transcriptional reprogramming, ESR1 mutations, and novel targets and treatment'

LBCA Interview with Rinath Jeselsohn, MD: Understanding the Features of the Estrogen Receptor in ILCПодробнее

LBCA Interview with Rinath Jeselsohn, MD: Understanding the Features of the Estrogen Receptor in ILC

ILC 2021 - Scientific Sessions Day 1 - AfternoonПодробнее

ILC 2021 - Scientific Sessions Day 1 - Afternoon